13102
|

Influence of cuff stiffness on hemodynamics and perceived cuff pressure in the upper limbs in men and women: implications for practical training to limit blood flow restriction BMC Sports sciences, medicine and rehabilitation

 

All participants (demographic and anthropometric data are shown in Table 1) successfully completed the experimental sessions without side effects, except for some cases of mild tingling in the fingers at the end of the measurements. Regarding RTD, three men had to be excluded from the data analyzes because the occlusion of arterial blood flow was not possible with the MS and/or LS cuff due to the painful pinching of the skin fold and the stretching of the cuff up to the yield point. In addition, one female was excluded from data analyzes for vsysRPP, SMO2and tHb because arterial blood flow was already occluded at 20% overlap using the HS cuff.

Table 1 Participant characteristics expressed as means ± standard deviations

Overlap to occlusion

There was a main effect of cuff (F2.62 = 175.679, P< 0.001, theP2= 0.850) and post hoc analysis indicated that RTD was lower in the HS compared to the MS (MD = -13.06% (-16.18 to -9.93%), P< 0.001, D= 2.06) and LS cuff (MD = -23.78% (-26.90 to -20.65%), P< 0.001, D= 3.75). In addition, RTD was also lower using the MS compared to the LS cuff (MD = -10.72% (-13.85 to -7.60%), P< 0.001, D= 1.69). Descriptive data are shown in Table 2; Fig. 3.

Table 2 Hemodynamic, physiological and perceptual responses to progressive practical blood flow restrictions (10%, 20% and 30% overlap relative to the individual’s upper arm circumference) using a high stiffness (HS), medium stiffness cuff ( MS) and low stiffness (LS). Data are expressed as means ± standard deviations
Fig. 3
figure 3

Percent overlap needed for arterial occlusion in the high stiffness (HS), medium stiffness (MS), and low stiffness (LS) cuff. A significant difference between LS and MS is shown as *p<0.05, **p < 0.01, ***p < 0.001 and #p<0.05, ##p < 0.01, ### p < 0.001 respectively

Peak systolic velocity of blood flow

There was an overlap × cuff interaction (F3,642,120,192 = 71.952, P< 0.001, theP2= 0.686) and a main effect of overlap (F1,770,58,422 = 161.427, P< 0.001, theP2= 0.830) and cuff (F2.66 = 50.380, P< 0.001, theP2= 0.604) for vsys. Post hoc analysis showed that vsys was lower at 30% overlap in each cuff compared to baseline (HS: MD = -62.67 cm s− 1(-70.97 to -54.37 cm s− 1 ), P< 0.001, D= 3.95; MS: MD = -21.53 cm s− 1(-29.83 to -13.24 cm s− 1 ), P< 0.001, D= 1.36; LS: MD = -11.02 cm s− 1(-19.31 to -2.72 cm s− 1 ), P< 0.001, D= 0.69). Furthermore, when the HS cuff was applied, vsys was also lower at 20% overlap compared to baseline (MD = -20.51 cm s− 1(-28.80 to -12.21 cm s− 1 ), P< 0.001, D= 1.29). As for cuff differences, vsys was lower at 20% and 30% overlap using the HS cuff compared to the MS (MD = -16.89 cm s− 1(-26.08 to -7.70 cm s− 1 ), P< 0.001, D= 1.07 and MD = -39.91 cm s− 1(-49.11 to -30.71 cm s− 1 ), P< 0.001, D= 2.52, respectively) and the LS cuff (MD = -17.60 cm s− 1(-26.80 to -8.41 cm s− 1 ), P< 0.001, D= 1.11 and MD = -53.99 cm s− 1(-63.18 to -44.79 cm s− 1 ), P< 0.001, D= 3.40 respectively). Furthermore vsys was also lower at 30% overlap using the MS compared to the LS cuff (MD = -14.08 cm s− 1(-23.27 to -4.88 cm s− 1), P< 0.001, D= 0.89). Descriptive data are shown in Table 2; Fig. 4.

Fig. 4
figure 4

Peak systolic velocity of blood flow (A) and assessment of perceived cuff pressure (B) in response to progressive practical pressure on blood flow restriction, expressed as percent overlap in relation to the individual’s arm circumference. A significant difference between LS and MS is shown as *p<0.05, **p < 0.01, ***p < 0.001 and #p<0.05, ##p < 0.01, ###p < 0.001 respectively

Assessment of perceived cuff pressure

An overlap × cuff interaction (F3,946,130,209 = 13.994, P< 0.001, theP2= 0.298) and a main effect of overlap (F1,668,55,046 = 674.771, P< 0.001, theP2= 0.953) and cuff (F2.66 = 11.067, P< 0.001, theP2= 0.251) was found for RPP. A post hoc analysis showed that RPP increased at each %overlap stage compared to baseline for all three cuffs (HS10%: MD = 1.57 au (0.98 to 2.17 au), P< 0.001, D= 1.51; HS20%: MD = 3.80 au (3.21 to 4.40 au), P< 0.001, D= 3.66; HS30%: MD = 6.41 au (5.82 to 7.00 au), P< 0.001, D= 6.16; MS10%: MD = 1.54 au (0.94 to 2.13 au), P< 0.001, D= 1.48; MS20%: MD = 3.32 au (2.72 to 3.91 au), P< 0.001, D= 3.19; MS30%: MD = 5.03 au (4.44 to 5.63 au), P< 0.001, D= 4.84; LS10%: MD = 1.46 au (0.87 to 2.05 au), P< 0.001, D= 1.40; LS20%: MD = 3.18 au (2.59 to 3.77 au), P< 0.001, D= 3.05; LS30%: MD = 4.95 au (4.36 to 5.55 au), P< 0.001, D= 4.76). Regarding differences between cuffs, RPP was higher using the HS cuff with 20% overlap compared to the LS cuff (MD = 0.71 au (0.06 to 1.37 au), P= 0.016, D= 0.69) and with an overlap of 30% compared to Member States (MD = 1.43 (0.78 to 2.09 au), P< 0.001, D= 1.38) and LS cuff (MD = 1.54 au (0.89 to 2.19 au), P< 0.001, D= 1.48). Descriptive data are shown in Table 2; Fig. 4.

Oxygenation of the muscles

SMO2: There was an overlap × cuff interaction (F2,374,78,326 = 3.232, P= 0.037, theP2= 0.089) and a main effect of overlap (F1,297,42,808 = 404,914.= P< 0.001, theP2= 0.925) and gender (F1.33 = 5.096, P= 0.031, theP2= 0.134) for SMO2. Post hoc analysis showed that SMO2 was lower at 20% overlap (HS: MD = -9.94% (-12.43 to -7.45%), P< 0.001, D= 1.15; MS = -8.28% (-10.77 to -5.78%), P< 0.001, D= 0.96; LS: MD = -7.42% (-9.98 to -5.00%), P< 0.001, D= 0.87) and 30% overlap (HS: MD = -17.46% (-19.95 to -14.97%), P< 0.001, D= 2.02; MS: MD = -14.91% (-17.42 to -12.42%), P< 0.001, D= 1.72; LS: MD = -13.79% (-16.28 to -11.30%), P< 0.001, D= 1.59) compared to baseline. Furthermore, the main effect of sex indicated that regardless of overlap and cuff used, SMO2 was lower in men than in women (MD = -5.16% (-9.80 to -0.51%), P= 0.031, D= 0.60).

tHb: An overlap × cuff (F3,072,101,386 = 6,440, P< 0.001, theP2= 0.163) and overlap × sex interaction (F1,187,39,158 = 14.814, P< 0.001, theP2= 0.310) and a main effect of overlap (F1,187,39,158 = 117,125.= P< 0.001, theP2= 0.780) and gender (F1.33 = 27.981, P< 0.001, theP2= 0.459) was found for tHb. Post hoc tests showed that tHb was higher at 20% overlap (HS: MD = 0.13 au (0.09 to 0.18 au), P< 0.001, D= 0.45; MS: MD = 0.10 au (0.05 to 0.14 au), P< 0.001, D= 0.32; LS: MD = 0.06 au (0.02 to 0.11 au), P< 0.001, D= 0.20) and 30% overlap (HS: MD = 0.22 au (0.18 to 0.27 au), P< 0.001, D= 0.75; MS: MD = 0.17 au (0.12 to 0.21 au), P< 0.001, D= 0.55; LS: MD = 0.15 au (0.10 to 0.19 au), P< 0.001, D= 0.45) compared to baseline. Moreover, tHb was already higher at a 10% overlap using the HS (MD = 0.05 au (0.00 to 0.09 au), P= 0.018, D= 0.16) compared to baseline. Regarding sex differences, post hoc analysis showed that regardless of cuff, tHb was higher by 10% (MD = 0.06 au (0.01 to 0.10 au), P= 0.003, D= 0.20), 20% (MD = 0.15 au (0.11 to 0.20 au), P< 0.001, D= 0.52) and 30% overlap (MD = 0.24 au (0.19 to 0.29 au), P< 0.001, D= 0.80) in men, while in women tHb was only higher during a 30% overlap compared to baseline (MD = 0.12 au (0.07 to 0.16 au), P< 0.001, D= 0.39). In addition, tHb was higher in men compared to women at baseline (MD = 0.51 au (0.31 to 0.70 au), P< 0.001, D= 1.69). Descriptive data are shown in Table 2.

Source link

Similar Posts

  • | |

    How are corticosteroids administered? – Bone and joint specialists

      Do you suffer from joint pain? Corticosteroids may be helpful if you have joint pain. These medications reduce inflammation in the body and come in different forms. You can take them orally, nasally, topically or by injection. Specifically for joint pain relief, injections are the most successful approach. Injection administration method The drug is…

  • Managing Hypermobile Knees Effectively | Tips And Info

    Welcome to our comprehensive guide on managing hypermobile knees. In this article, we will provide you with valuable tips and information on how to effectively deal with knee instability and hypermobility, as well as ways to alleviate knee pain and promote joint health. Key Takeaways: Hypermobile knees can cause pain and instability due to very…

  • Impact of DMCA Takedowns on Fitness Sites

    Did you know that a staggering 40% of DMCA takedown notices received by the company behind WordPress, Automattic, are invalid or false? These takedown notices, which are intended to protect copyrighted material, often have unintended consequences on health and fitness websites. With a significant number of notices being bogus, legitimate content on these websites is…

  • |

    Failed knee replacement symptoms

    What if the relief you expected after your joint procedure never arrives? This unsettling question faces a small percentage of individuals each year. While statistics show that 85% to 90% of patients enjoy successful outcomes for 15 to 20 years after their initial knee replacement surgery, some do not. failed knee replacement symptoms We understand that persistent discomfort following this major operation can be a source of deep frustration. It can severely limit your mobility and daily life. Our guide is here to shed light on the various signs that may indicate your implant is not performing as designed. Identifying these indicators early is critically important. It ensures you get the right medical attention and potential intervention from a qualified specialist. If you experience persistent pain and stiffness, understanding the next steps is vital. We will walk you through common warning signs, the diagnostic process, and the treatment paths available to restore your comfort and movement. Key Takeaways Most knee replacement procedures are highly successful for many years. Recognizing early warning signs of a problem is crucial for your health. Specialized care models, like the one at University of Utah Hospital, combine expert teams for complex cases. Persistent pain, swelling, or instability after recovery should not be ignored. Several effective treatment options exist to address implant issues. Early consultation with an orthopedic surgeon can lead to better outcomes. Your long-term mobility and quality of life are the ultimate goals. Understanding Knee Replacement Surgery Modern orthopedic medicine offers a reliable solution for severe joint damage through artificial joint implantation. This procedure aims to restore comfortable movement when natural cartilage wears down. knee replacement surgery components How Knee Replacements Work During this operation, surgeons remove damaged joint surfaces. They replace them with precisely engineered metal and plastic components. These artificial parts are designed to glide smoothly. They mimic your joint’s natural motion, reducing discomfort. Fixation Method How It Works Key Consideration Cemented Fixation Special bone cement bonds the implant directly to your bone. Provides immediate, strong stability after the operation. Biologic Fixation The bone grows into a porous coating on the device over time. Creates a durable, long-term bond without cement. Surgeon’s Choice The method is selected based on your bone quality and age. Each technique has specific advantages for different situations. Long-Term Expectations and Implant Lifespan Most modern devices are engineered for durability. A typical lifespan ranges from 15 to 20 years. “The longevity of a joint implant depends on multiple factors, including the patient’s activity level and overall bone health.” We emphasize that these components are not indestructible. They experience natural wear from daily use over time. Regular monitoring helps ensure your artificial joint functions well for as long as possible. Your activity choices and general health play significant roles. Recognizing Failed Knee Replacement Symptoms When an artificial joint doesn’t function as intended, your body sends distinct signals that demand attention. Learning to identify these signs is crucial for your long-term health and mobility. Persistent Pain and Swelling Persistent pain in the knee joint that lingers long after the typical recovery period is a primary indicator. This pain isn’t normal soreness. It often presents as a deep, constant ache. Swelling around the knee joint that refuses to fade with rest is another red flag. Persistent pain and swelling are common companions. They can suggest underlying issues like inflammation or component loosening. Instability and Changes in Joint Function A feeling of instability, where your leg might buckle, is alarming. This instability often feels like the joint is giving way when you put weight on it. You might also notice a noticeable decline in how well it moves. Stiffness, developing a limp, or hearing odd popping noises are critical functional changes. We encourage you to monitor these signs closely. They are the primary indicators that your implant may require further clinical assessment. Common Causes of Knee Replacement Failure…

One Comment

Leave a Reply

Your email address will not be published. Required fields are marked *